(Total Views: 282)
Posted On: 04/21/2018 1:47:41 PM
Post# of 72440
We're doing lots of pre-clinical work. IPIX is not standing still while business development continues.
K reformulation (oral).
B-UP formulation optimization (foam?).
B-OM formulation optimization (sachets, foam, gel, etc.).
B for topical applications (preclinical testing + formulation)
Aside from the P results though, I believe you are correct that a significant business development will be the next catalyst.
K reformulation (oral).
B-UP formulation optimization (foam?).
B-OM formulation optimization (sachets, foam, gel, etc.).
B for topical applications (preclinical testing + formulation)
Aside from the P results though, I believe you are correct that a significant business development will be the next catalyst.
(0)
(0)
The Ghost of Phteven. All posts my opinion and speculation only.
Scroll down for more posts ▼